Vedolizumab Dose Escalation Improves Therapeutic Response in a Subset of Patients with Ulcerative Colitis is a research paper published in Digestive Diseases and Sciences (2020). On theSindex it has a DataRank of 0. It has been cited 28 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: TL1TR001997
U.S. Department of Veterans Affairs
Grant: I01CX001353
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: R21DK118954
National Institutes of Health
Grant: 5I01CX001353-02
The role of Axin2+ stem cells in ulcer healing during colitis.
National Institutes of Health
Grant: 1R21DK118954-01
Peripheral Blood Exosome Lipids as Biomarkers of Disease Activity in Crohn’s Disease
National Institutes of Health
Grant: 5UL1TR001998-02
Kentucky Center for Clinical and Translational Science
National Institutes of Health
Grant: 5TL1TR001997-07
NRSA Training Core
FWCI
3.57
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals